Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.
Clinical trial NCT03525392 · TERMINATED
Trial details
- NCT number
- NCT03525392
- Sponsor
- Ipsen
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-03
- Primary completion
- 2020-04-03
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.